Meg Columbia-Walsh has joined Cognizant as the firm’s Digital Healthcare lead. In the new role, she has been charged with supporting the firm in further expanding its digital healthcare offerings related to where payers, providers and data analysis meet.
Meg Columbia-Walsh joins Cognizant from EY. At the Big Four firm, she was a Partner and acted as the firm’s Global Lead in its Digital Transformation and Marketing Excellence practice for the Life Sciences since 2015, when her own company Inverse Mobile was bought by EY. Columbia-Walsh founded Inverse Mobile in 2012 and acted as the CEO of the strategic mobile and social advertising and marketing agency. Concurrently, she was hired by Facebook in 2013 to head up its Global Marketing Solutions division. Prior to founding her own firm, she was the President of Augme Mobile Health Group between 2010 and 2012. Other roles held by Columbia-Walsh include that of President at EuroRSCG Life, Managing Partner and President of CommonHealth’s Consumer and ebusiness, Managing Director at Faith Popcorn's BrainReserve, founder and CEO of CBSHealthwatch and CEO of Oncology.com. Prior consulting experience includes her 3 year stint as Partner in EY’s consulting practice, and its successor Capgemini, between 2001 and 2004.
Columbia-Walsh holds a Bachelor degree in Business, Communications, Pre-Med and Women’s Studies from Rider University, and a Post-Baccalaureate in Pre-Med from Columbia University.
In her new role at Cognizant as Global lead of the firm’s Digital Healthcare practice she has been charged with building a digital team. The practice will focus on strategic planning between various health stakeholders, including payers, providers and data analysis. The new role will see her leverage her many years of experience in the business area she herself helped develop through her various entrepreneurial efforts. “I was sort of an accidental entrepreneur,” she explains. “I think the one thing I had was a strength in anticipating trends related to technology and then being able to translate them from a business standpoint.”